We found that SF3A2 (splicing factor 3A2) was downregulated in apatinib-treated tumor xenograft tissues compared with that without apatinib treatment (Supplementary Fig. S8A), and silencing of SF3A2 increased circRACGAP1 expression (Supplementary Fig. S8B). The gene discussed is SF3A2; the disease is neoplasm.